D68.62
Lupus anticoagulant syndrome
Clinical Classification Guidelines
Inclusion Terms
- Lupus anticoagulant
- Presence of systemic lupus erythematosus [SLE] inhibitor
Excludes Type 1
- lupus anticoagulant (LAC) finding without diagnosis (R76.0)
Excludes Type 2
- anticardiolipin syndrome (D68.61)
- antiphospholipid syndrome (D68.61)
- lupus anticoagulant (LAC) with hemorrhagic disorder (D68.312)
Medical Intelligence & Overview
Lupus anticoagulant syndrome is a condition characterized by the presence of certain antibodies in the blood that interfere with normal blood clotting. Despite its name suggesting a bleeding risk, it is more often associated with an increased tendency for blood clots. It is linked to autoimmune disorders, particularly systemic lupus erythematosus (SLE), and can lead to complications such as deep vein thrombosis or stroke. Recognizing this condition is important for managing associated health risks and preventing serious blood clotting problems.
Causes & Symptoms
Clinical Causes: Presence of lupus anticoagulant antibodies, which are abnormal proteins that interfere with blood clotting tests Underlying autoimmune disorders, especially systemic lupus erythematosus (SLE) Other autoimmune conditions or chronic inflammatory states Certain infections or medications that may trigger the production of these antibodies Genetic predisposition in some cases
Key Symptoms: Unusual blood clots forming in veins or arteries, leading to conditions such as deep vein thrombosis or strokes Repeated pregnancy miscarriages, especially in the second or third trimester Persistent fatigue or general feeling of unwellness Signs of blood clots like swelling, redness, or pain in affected limbs No symptoms in some cases, with the condition being detected during blood tests for other issues
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves blood tests that detect the presence of lupus anticoagulant antibodies. Commonly used tests include the dilute Russell’s viper venom time (dRVVT) and others that assess blood clotting function. Medical history, especially of blood clots or pregnancy complications, plays a crucial role. Additional testing may be performed to rule out other conditions and confirm the diagnosis.
Treatment Protocols: Managing lupus anticoagulant syndrome focuses on reducing the risk of blood clots. Treatment options may include anticoagulant medications like warfarin or low-molecular-weight heparin. Regular monitoring of blood clotting status and managing any underlying autoimmune disorders are vital. Lifestyle modifications, such as avoiding smoking and controlling other risk factors for clotting, are also recommended. The specific treatment plan is tailored to each individual based on their health profile and risk factors.
Clinical Advice & FAQs
Billing Guidance
Is D68.62 a billable ICD-10 code?
Yes, D68.62 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D68.62?
Clinical documentation must specify the nature of Lupus anticoagulant syndrome and any associated comorbidities for accurate reporting.
Cite this Clinical Reference